Petauri Expands Global Medical Communications Capabilities With Acquisition of Emotive
Acquisition strengthens Petauri's medical communications collective, Petauri Advance, with expanded global scale and deep scientific, strategic, and creative expertise
NASHVILLE, Tenn., Nov. 10, 2026 /PRNewswire/ -- Petauri, a purpose-built pharmaceutical services platform, today announced the acquisition of Emotive, a global medical communications agency. The acquisition further strengthens the organization's medical communications collective, Petauri Advance, and expands its global reach by adding scientific, strategic, and creative expertise.
"As therapies become increasingly complex, our clients need partners that can not only understand the science behind them but translate it for the people who ultimately shape patient care," said Dan Renick, CEO of Petauri. "Emotive does just that by bridging scientific precision and industry-recognized creativity to inspire change and help lifesaving treatments reach those who need them most."
Founded in 2013, Emotive has built a strong reputation for bringing strategic, scientific, and creative thinking to some of healthcare's most complex challenges, with particular depth in neuroscience and immunology, complemented by experience in oncology, rare disease, and other complex areas of medicine. The business will join Petauri Advance's existing strategic medical agencies, DRIVE, PROPEL, MOMENTUM, BluPrint Oncology, Verascity Science, and Cogency. Together, these agencies strengthen Petauri Advance's ability to deliver integrated medical communications spanning strategic planning, insight generation, disease education, promotional communications, publications, and congresses and symposia.
"Joining Petauri represents an exciting next chapter for Emotive," said Chris Edmonds, Founder and CEO of Emotive, who will now serve as Executive Advisor within the organization. "Emotive was built to turn complex science into communications that inspire meaningful change. Together with Petauri, we can build on that ambition, expanding what we can bring to clients while preserving the partnership they value."
Lisa Hefner, Group President, Petauri Advance, added, "The strength of this combination lies in the complementary expertise of our teams, our shared core values, and the aligned vision for the future of healthcare communications. Together, our teams bring specialized knowledge across geographies, therapeutic areas, and disciplines to deliver more connected, impactful solutions earlier in the asset life cycle, ultimately helping to improve patient outcomes."
Petauri now numbers more than 600 global professionals spanning market access and scientific communications capabilities. In partnership with hundreds of clients, Petauri works to improve patient outcomes by demonstrating the clinical and economic value of innovative medicines and treatments to a wide range of global stakeholders, speeding access to life-changing and often lifesaving medical advances.
About Petauri
Petauri is a purpose-built pharmaceutical services platform based in Nashville, Tennessee. Founded by CEO Dan Renick in partnership with Oak Hill Capital, the platform is launching, acquiring, and combining best-in-class companies with recognized expertise in life sciences, health systems, scientific communications, and market access.
Since its founding in 2023, the platform has launched Petauri Advisors and acquired The Kinetix Group, the agencies of FORCE Communications, Mtech Access, Delta Hat, the agencies of the Brightly Network, Formulary Insights, Artia Solutions, and Franklin Pharmaceutical Consulting, all now Powered by Petauri™. The legacy organizations now comprise Petauri's six business units: Petauri Advance, Petauri Advisors, Petauri Evidence, Petauri Kinect, Petauri MAx, and Artia Solutions. Oak Hill will invest more than $250 million of equity capital in this initiative from its latest fund (OHCP VI). The platform works with pharmaceutical and life sciences clients to improve patient outcomes by establishing the scientific, economic, humanistic, and societal value of medical advances.
From strategy to implementation, Petauri seamlessly supports these clients with a wide range of innovative solutions that speed patient access to life-changing care. For more information, please visit www.petauri.com.
Media Contact:
Liz Gulino
SOURCE Petauri
Share this article